The Zambon Group Overview
- Year Founded
-
1906
- Status
-
Private
- Employees
-
2,798
- Latest Deal Type
-
Debt
- Latest Deal Amount
-
$64.2M
The Zambon Group General Information
Description
Manufacturer of pharmaceutical and chemical products intended to find treatment solutions for specialized diseases. The company's products include active and intermediate ingredients for severe respiratory diseases, Parkinson's disease, cough and cold, women's health, and pain, enabling patients to choose the desired products.
Contact Information
Website
www.zambon.comCorporate Office
- Via Lillo del Duca, 10
- 20091 Bresso(Milan)
- Italy
Corporate Office
- Via Lillo del Duca, 10
- 20091 Bresso(Milan)
- Italy
The Zambon Group Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Debt - General | 01-Dec-2012 | $64.2M | Completed | Generating Revenue |
The Zambon Group Comparisons
Industry
Financing
Details
The Zambon Group Competitors (49)
One of The Zambon Group’s 49 competitors is MS Pharma, a Formerly PE-Backed company based in Amman, Jordan.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| MS Pharma | Formerly PE-Backed | Amman, Jordan | ||||
| Menarini Group | Corporation | Florence, Italy | ||||
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| Theravance Biopharma | Corporation | San Francisco, CA | ||||
| Verona Pharma | Private Debt Financed | London, United Kingdom |
The Zambon Group Patents
The Zambon Group Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4282410-A1 | Association of colistin and n-acetalcysteine in the treatment of bacterial infections by p. aeruginosa in a mature biofilm phase of growth | Pending | 27-May-2022 | ||
| AU-2023274384-A1 | Antimicrobial association in the treatment of p. aeruginosa biofilm-associated infections | Pending | 27-May-2022 | ||
| CA-3242420-A1 | Pharmaceutical composition comprising tigecycline | Pending | 13-Dec-2021 | ||
| AU-2022415377-A1 | Pharmaceutical composition comprising tigecycline | Pending | 13-Dec-2021 | ||
| EP-4447928-A1 | Pharmaceutical composition comprising tigecycline | Pending | 13-Dec-2021 | A61K9/0075 |
The Zambon Group Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
The Zambon Group Investments & Acquisitions (14)
The Zambon Group’s most recent deal was a Accelerator/Incubator with Kadence Bio for . The deal was made on 23-Sep-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Kadence Bio | 23-Sep-2024 | Accelerator/Incubator | Drug Discovery | ||
| Hyivy Health | 19-Jul-2024 | Seed Round | Therapeutic Devices | ||
| Breath Therapeutics | 25-Jul-2019 | Merger/Acquisition | Drug Discovery | ||
| Plusimple | 22-Oct-2017 | Accelerator/Incubator | Other Healthcare Technology Systems | ||
| Savara | 06-Jun-2017 | Public Investment 2nd Offering | Biotechnology |
The Zambon Group Subsidiaries (4)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Zetacube S.R.L. O In Forma Abbreviata O Commerciale Z-Cube | Other Commercial Services | Bresso, Italy | 2006 |
| Zcube | Corporate Venture Capital | Milan, Italy | |
| Italiassistenza | Other Healthcare Services | Reggio Emilia, Italy | |
| Laboratoires Laphal | Pharmaceuticals | Allauch, France |
The Zambon Group FAQs
-
When was The Zambon Group founded?
The Zambon Group was founded in 1906.
-
Where is The Zambon Group headquartered?
The Zambon Group is headquartered in Bresso, Italy.
-
What is the size of The Zambon Group?
The Zambon Group has 2,798 total employees.
-
What industry is The Zambon Group in?
The Zambon Group’s primary industry is Drug Discovery.
-
Is The Zambon Group a private or public company?
The Zambon Group is a Private company.
-
What is The Zambon Group’s current revenue?
The current revenue for The Zambon Group is .
-
How much funding has The Zambon Group raised over time?
The Zambon Group has raised $64.2M.
-
Who are The Zambon Group’s competitors?
MS Pharma, Menarini Group, Genentech, Theravance Biopharma, and Verona Pharma are some of the 49 competitors of The Zambon Group.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
